Clinical Trials Logo

Filter by:
NCT ID: NCT06434519 Not yet recruiting - Clinical trials for Rosacea, Erythematotelangiectatic

Metronidazole SC Penetrance With Moisturizers

Start date: August 2024
Phase: N/A
Study type: Interventional

Topical metronidazole is a widely used first line treatment for erythemotelangiectatic and inflammatory rosacea. Commonly, a moisturizer is also used to restore the skin barrier and reduce inflammation. The purpose of this study is to assess the whether the common practice of applying moisturizer prior to topical metronidazole affects this medication's stratum corneum penetrance in rosacea patients. Participants will have one research office visit that will consist of having a randomly assigned combination of metronidazole and one of four moisturizers applied to their face, followed by non-invasive tape stripping of skin at the 1 hour and 4 hour time points. These tape strip samples will be analyzed with liquid chromatography mass spectrometry (LC-MS) for assessment of metronidazole penetrance in the stratum corneum in the presence of moisturizers. The target population will be rosacea patients in the age range of 18-60 years of age. This study has minimal risks/safety issues as topical metronidazole is an already FDA approved medication with an indication for rosacea and all investigated moisturizers are over-the-counter formulations commonly used within the rosacea patient population. Tape stripping will remove 5 levels of superficial stratum corneum, and will not result in bleeding, scarring, or other prolonged cosmetic disfigurement. Small, transient bruising may result from tape strip collection. The collected samples will have no to minimal biohazard risk, as the collected specimen for analysis will only contain skin scale; samples will be extracted with organic solvents and decontaminated with a 0.2 micron nylon filter prior to analysis on the LC-MS instrumentation.

NCT ID: NCT06434402 Recruiting - Cancer Clinical Trials

A Virtual, Group-Based, Expressive Writing Intervention for Survivors of Adolescent and Young Adult Cancer

Start date: May 22, 2024
Phase: N/A
Study type: Interventional

To learn more about the experiences of adolescent and young adult cancer survivors and investigate whether a group-based writing intervention can help to improve quality of life of adolescent and young adult cancer survivors.

NCT ID: NCT06434363 Not yet recruiting - Systemic Sclerosis Clinical Trials

Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Disorders

Start date: November 30, 2024
Phase: Phase 1/Phase 2
Study type: Interventional

The goal of Safety Lead-In is to confirm the safety of tafasitamab when given to patients with SSc, SLE, and LN. The goal of Phase 1 is to find the recommended dose of AD-PluReceptor-NK cells in combination with tafasitamab and lymphodepleting chemotherapy that can be given to patients with the disease. The goal of Phase 2 is to learn if the dose of AD-PluReceptor-NK cells found in Phase 1 in combination with tafasitamab and lymphodepleting chemotherapy can help to control the disease.

NCT ID: NCT06434350 Not yet recruiting - Clinical trials for Advanced Bladder Cancer

Enfortumab Vedotin With Radiation for Locally Advanced Bladder Cancer (CONSOLIDATE)

Start date: November 29, 2024
Phase: Phase 1/Phase 2
Study type: Interventional

To learn if the combination of enfortumab vedotin plus radiation therapy could help to control the disease.

NCT ID: NCT06434337 Not yet recruiting - Clinical trials for Human Papillomavirus

Evaluation of a Novel Point-of-Care Diagnostic Test for Human Papillomavirus (HPV)

Start date: November 29, 2024
Phase:
Study type: Observational

To learn if new HPV tests can provide the same results as standard HPV tests. The findings from this study may aid in the development of new HPV tests that require less equipment and are more accessible.

NCT ID: NCT06434324 Not yet recruiting - Pleural Infection Clinical Trials

Pleural Space Saline Irrigation in Addition to Standard Intrapleural Thrombolytic Therapy in Empyema/Complicated Parapneumonic Effusion

Start date: July 1, 2024
Phase: N/A
Study type: Interventional

The purpose of this study is to see if there is any benefit in adding saline irrigation through a chest tube to the standard course of treatment for people diagnosed or suspected of having a pleural space infection.

NCT ID: NCT06434233 Recruiting - Opioid Use Clinical Trials

Opioid Use After Laparoscopic Salpingectomy

Start date: April 25, 2024
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate patient-reported post-operative pain scores following minimally invasive tubal sterilization procedures to determine if a multimodal, non-opioid pain control regimen is non-inferior to a pain control regimen including opioids. The study team hypothesizes that with extensive counseling on pain management, multimodal medication use, and expectation with non-opioid methods can effectively eliminate the need for opioid prescriptions after laparoscopic salpingectomy.

NCT ID: NCT06434207 Not yet recruiting - Clinical trials for Congenital Heart Disease

Extracellular Vesicle Micro RNA Profiling in Congenital Heart Disease: Fetal-Maternal Regulation in Neonatal Thrombosis

EVmiRNA
Start date: June 1, 2024
Phase:
Study type: Observational

Newborns with congenital heart disease (CHD) are at increased risk of developing postpartum and postoperative blood clots after cardiac surgery. The molecular mechanisms that are responsible for the clotting profile predisposing children to blood clots in the early stages of life are currently not well described. The goal of this proposal is to prospectively collect plasma samples from ten (10) neonates with antenatal diagnosis of severe congenital heart disease (CHD) to better understand mechanisms responsible for abnormal clotting in the perioperative period.

NCT ID: NCT06434181 Completed - Healthy Clinical Trials

Beetroot Juice for Boosting Immunity During a Time of Stress.

Start date: April 11, 2022
Phase: Phase 2
Study type: Interventional

The purpose of the present study is to explore the effects of a dietary nitrate supplement (i.e., beetroot juice) on nitric oxide levels, immunity, mood, and cardiovascular activity during and following final exam stress in healthy individuals.

NCT ID: NCT06434168 Not yet recruiting - Heart Failure Clinical Trials

Impact of Yoga on Cognitive Function

Start date: July 1, 2024
Phase: N/A
Study type: Interventional

Mild cognitive impairment is highly prevalent in patients with heart failure and results in poor well-being and quality of life. While yoga has proven effective in promoting cognitive health in older adults through its gentle movements, controlled breathing, and meditation, its effects on patients with heart failure remain unknown. Therefore, this feasibility and pilot study plans to deliver a 12-week yoga intervention and test its effects on cognitive function in patients with heart failure and mild cognitive impairment.